These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27966038)

  • 1. GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling.
    Koch C; Samareh B; Morishima T; Mir P; Kanz L; Zeidler C; Skokowa J; Welte K
    Ann Hematol; 2017 Mar; 96(3):345-353. PubMed ID: 27966038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway.
    Skokowa J; Lan D; Thakur BK; Wang F; Gupta K; Cario G; Brechlin AM; Schambach A; Hinrichsen L; Meyer G; Gaestel M; Stanulla M; Tong Q; Welte K
    Nat Med; 2009 Feb; 15(2):151-8. PubMed ID: 19182797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective G-CSFR signaling pathways in congenital neutropenia.
    Skokowa J; Welte K
    Hematol Oncol Clin North Am; 2013 Feb; 27(1):75-88, viii. PubMed ID: 23351989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of myeloid-specific transcription factors in congenital neutropenia.
    Skokowa J; Welte K
    Ann N Y Acad Sci; 2009 Sep; 1176():94-100. PubMed ID: 19796237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia.
    Guba SC; Sartor CA; Hutchinson R; Boxer LA; Emerson SG
    Blood; 1994 Mar; 83(6):1486-92. PubMed ID: 7510142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of IL-3, GM-CSF and G-CSF in an adult with congenital neutropenia.
    Miyachi H; Nakamura Y; Shimizu H; Watanabe K; Arimori S; Ando Y
    Int J Hematol; 1992 Oct; 56(2):113-8. PubMed ID: 1384774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN; Papadopoulos NE; Chawla SP; Fenoglio C; Cooper S; Buescher ES; Frenck RW; Holian A
    J Clin Oncol; 1992 Aug; 10(8):1266-77. PubMed ID: 1634916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-CSF and GM-CSF in Neutropenia.
    Mehta HM; Malandra M; Corey SJ
    J Immunol; 2015 Aug; 195(4):1341-9. PubMed ID: 26254266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyshematopoiesis in combined immune deficiency with congenital neutropenia.
    Gasparetto C; Smith C; Firpo M; Dennig D; Small T; Gillio AP; Lichtenberg R; O'Reilly RJ; Moore MA
    Am J Hematol; 1994 Jan; 45(1):63-72. PubMed ID: 8250011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor.
    Shitara T; Ijima H; Yugami S; Sotomatu M; Kuroume T
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):167-72. PubMed ID: 7513137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of a Patient With Congenital Biallelic CSF3R Mutation With GM-CSF.
    Yilmaz Karapinar D; Özdemir HH; Akinci B; Yaşar AŞ; Siviş ZÖ; Onay H; Özkinay F
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):e164-e166. PubMed ID: 30499904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil Maturation and Survival Is Controlled by IFN-Dependent Regulation of NAMPT Signaling.
    Siakaeva E; Pylaeva E; Spyra I; Bordbari S; Höing B; Kürten C; Lang S; Jablonska J
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
    Ravaud A; Chevreau C; Cany L; Houyau P; Dohollou N; Roché H; Soubeyran P; Bonichon F; Mihura J; Eghbali H; Tabah I; Bui BN
    J Clin Oncol; 1998 Sep; 16(9):2930-6. PubMed ID: 9738560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.